SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 31.91+2.0%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Douglas who wrote (292)11/16/1997 3:36:00 PM
From: Daniel Shaffer  Read Replies (1) of 455
 
What Else is in the Pipeline?

Thanks for your well-informed reply, Douglas.

I can't recall the source, but I heard that there is a close relationship
between PRCTD and Harvard Medical School. Maybe they are using
faculty as consultants, med. students as interns, etc.

At any rate, it strikes me odd that they should have so little trouble
raising capital privately unless they are disclosing information
and/or showing other products in the pipeline to those institutional
investors that they are not showing to their own stockholders.

Is that legal?

> Couldn't find any reference to pay cuts!
> Stanley C. Erck 1996 $231,000
> Michael J. Higgins 1996 $102,000"

Pay is probably not out of line, but I'd feel a lot better if there
were big equity "carrots" for these guys.

> Stock ownership is too little:
> All current executive officers and directors as a group
> 7 persons............................469,074(before split) 2.3%

It is very disturbing that the upper management and directors
have so little to lose in terms of an equity stake.

If I were involved in a new venture about which I was truly
optimistic, I would be acquiring stock at the current prices.
The potential capital gains could be enormous, if......

This company is a real puzzle to me. Is it that their PR is so
lousy or that they just don't have much to say. The latter just
doesn't jive with their capability of attracting new capital.

Every struggling start-up that I've seen close-hand has found
it extremely difficult to impossible to attract new capital when
they are running out of money short of having a hot product
on the market!

Best wishes!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext